These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9580050)

  • 21. Signet ring cell mesothelioma; A diagnostic challenge.
    Wang H; Herath C
    Pathol Res Pract; 2019 Jul; 215(7):152462. PubMed ID: 31146976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratubal Pseudopapillary Histiocytic Hyperplasia: A New Histologic Variant in the Spectrum of Histiocytic Lesions Involving the Fallopian Tube.
    Tran TAN; Holloway RW
    Int J Gynecol Pathol; 2021 Jul; 40(4):369-375. PubMed ID: 33323856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpretation of pleural biopsy specimens and aspirates with the immunoperoxidase technique.
    Herbert A; Gallagher PJ
    Thorax; 1982 Nov; 37(11):822-7. PubMed ID: 6761889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signet-ring sinus histiocytosis: a reactive disorder that mimics metastatic adenocarcinoma.
    Guerrero-Medrano J; Delgado R; Albores-Saavedra J
    Cancer; 1997 Jul; 80(2):277-85. PubMed ID: 9217041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical profile of normal mesothelium and histiocytic/methothelial hyperplasia: a case report.
    Terada T
    Int J Clin Exp Pathol; 2011 Aug; 4(6):631-6. PubMed ID: 21904639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential diagnosis of preneoplastic lesions of the pleura and of early mesothelioma: immunohistochemical and morphological findings].
    Krismann M; Thattamparambil P; Simon F; Johnen G
    Pathologe; 2006 Mar; 27(2):99-105. PubMed ID: 16435096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation.
    Shi M; Fraire AE; Chu P; Cornejo K; Woda BA; Dresser K; Rock KL; Jiang Z
    Am J Surg Pathol; 2011 Jun; 35(6):878-82. PubMed ID: 21566519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histiocyte-rich reactive lymphoid hyperplasia of the liver: unusual morphologic features.
    Park HS; Jang KY; Kim YK; Cho BH; Moon WS
    J Korean Med Sci; 2008 Feb; 23(1):156-60. PubMed ID: 18303220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical mesothelial hyperplasia associated with bronchogenic carcinoma.
    Yokoi T; Mark EJ
    Hum Pathol; 1991 Jul; 22(7):695-9. PubMed ID: 1712750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histiocytic/mesothelial hyperplasia.
    Clement PB; Young RH
    Am J Surg Pathol; 1998 Aug; 22(8):1036-7. PubMed ID: 9706986
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathogenesis of nodular histiocytic hyperplasia in serous effusions.
    Naylor B
    Diagn Cytopathol; 2002 Jan; 26(1):68. PubMed ID: 11782092
    [No Abstract]   [Full Text] [Related]  

  • 32. Histiocytosis With Raisinoid Nuclei: A Unifying Concept for Lesions Reported Under Different Names as Nodular Mesothelial/Histiocytic Hyperplasia, Mesothelial/Monocytic Incidental Cardiac Excrescences, Intralymphatic Histiocytosis, and Others: A Report of 50 Cases.
    Michal M; Kazakov DV; Dundr P; Peckova K; Agaimy A; Kutzner H; Havlicek F; Daum O; Dubova M; Michal M
    Am J Surg Pathol; 2016 Nov; 40(11):1507-1516. PubMed ID: 27340746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
    Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
    Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selected topics in peritoneal pathology.
    Baker PM; Clement PB; Young RH
    Int J Gynecol Pathol; 2014 Jul; 33(4):393-401. PubMed ID: 24901399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodular mesothelial hyperplasia in hernia sacs: a benign reactive condition simulating a neoplastic process.
    Rosai J; Dehner LP
    Cancer; 1975 Jan; 35(1):165-75. PubMed ID: 1109769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mesothelioma and mesothelial hyperplasia].
    Li LY; Luo WC; Zhu YJ
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):328-31, 381. PubMed ID: 2269029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computerized interactive morphometry. A study of malignant mesothelioma and mesothelial hyperplasia in pleural biopsy specimens.
    Marchevsky AM; Gil J; Caccamo D
    Arch Pathol Lab Med; 1985 Dec; 109(12):1102-5. PubMed ID: 3840984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant mesothelioma eight years after a diagnosis of atypical mesothelial hyperplasia.
    Scurry J; Duggan MA
    J Clin Pathol; 1999 Jul; 52(7):535-7. PubMed ID: 10605410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomorphology of nodular histiocytic/mesothelial hyperplasia.
    Jin X; Jing X; McHugh JB; Pantanowitz L
    Diagn Cytopathol; 2022 Sep; 50(9):E264-E266. PubMed ID: 35582754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.